Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know it doesn’t mean that they going to definitely issue more shares but asking for an additional 30m on top of the 23.5m you still have to work with. Doesn’t make me feel comfortable
Yes so as of right now they still have 23.5m shares to pull from but I guess that might not be enough for whatever they are planning or its just enough and they are asking for additional 30m for the future if needed
Lol, another slap in the face to investors. I can only hope they don’t plan on raising cash at this low of a pps. That would explain why they are asking for more shares. For all of you that think Tony L is making any of these decisions. I think you’re crazy. He’s doing whatever the BOD tells him to do. Tick tock goes the little clock. We have until June to turn this around or it’s all over
Of course you don’t, wink wink!!!
The biggest RED FLAG was all the delays. I have seen it with so many companies and it usually doesn’t end well. Hoping for a different outcome here but with ever passing day and not a word. Things start to look worse
Red our favorite color here at Advaxis
Same old story!!! Just a different week. Hope they sell the company soon for a decent amount. Now we are looking for a new CEO after one just left with a boat load of shares and the current CEO was just awarded 100,000 shares I believe. For what? I don’t know! Tick Tock better start making some progress soon or we are in deep s***
Actually I believe it would be the perfect time to release good news. Something like Merck has finally decided to dip into their pockets and pay up for PSA. PR Thursday morning. Let the stock do its thing and then what would people talk about to their family and friends over the long holiday weekend, hmm!!!
I have screen shots of the jobs. There was a job listed for Director of Clinical operations but this one is Associate Director of clinical operations. Not sure if they are the same thing. Seems like a few others jobs might have been filled as well
I for one have not been happy with the performance of Advaxis this year but that is mostly because I thought we would never see this pps again. I did listen to the most recent webcast again and also listened to the short Q&A I somehow missed the first time. I personally purchased all my long shares in this range years ago. When most thought the sky was falling but knew if I wanted to get in at the bottom. This was my chance. Well some of you are getting that chance again and you should take it right NOW. If I didn't add over the last year in the 6's and 7's. I would be loading up again right now because I believe once again what I believed when I took a chance many years ago. Over the next 6 months you will see another big shift in the Advaxis pps that could even surpass that $30 high we once saw. If you have the guts!! Now is your chance
The next six months will be Advaxis last gasp of air. It will be sink or swim! Good luck
Square1, did you attend the conference because I didn't hear any Q&A after the presentation. My feed just cut of right at the end
So nothing new but already expected that. IND for ADXS-DAUL got pushed to 1Q 2018. Basically 2017 is over. No talks what so ever if they are in partnership talks but that's fine. I would rather be surprised. Happy holidays to all. See you next year
Still don't understand this ADXS-DAUL trial? We are the ones that have the best results ever for advanced cervical cancer. We are the ones that already have a phase 3 trial ongoing and trying to submit for early approval in Europe. We are the ones that now think we have specific bio-markers and data has shown that by adding BMY PD1 the results could improve drastically. So why are we paying for this trial. BMY should be begging us to let them pay and trying to negotiate them adding this to their pipeline.
What you can expect tomorrow at the conference. Whole lot of nothing!!!! The only milestone left was HOT - IND and I'll bet it gets moved to 2018 with everything else.
How the F did we get to this point. This is just ridiculous
SAME PATTERN KEEPS REPEATING. Fake little run ups like last Friday and then someone is dumping, dumping and dumping
Dan's pps at his new place of business seems to be headed in the right direction, lol
It should have also read
"Just delayed by about 6 months, lol!!"
I thought the delay was because a safety study needed to be completed but the he article reads once they receive conditional approval. Then they can complete the safety study, wow. How much longer until it receives market approval and I thought when they chose to go with the USDA. It was because the road to approval would be easier than through the FDA. That worked out well
$2.50 here we come. Wow talk about creating shareholder value, LAMEbardo. You have done nothing but destroy it since you arrived
News after hours today. Company sold for $8 a share. I'll take it!!!
2 medical conferences this week and not one WORD from our wonderful company
Sell this pos already!! Told you months ago, game over. Now all the tutes are slowly unloading their shares. Delays like ours don't just happen just because.
ADVAXIS PLEASE ALL I ASK IS THAT NEXT WEEK YOU SHOW US SOMETHING POSITIVE AT THE UPCOMING MEDICAL CONFERENCES. PLEASE FOR CRYING OUT LOUD!!!! SOMETHING NEW AND FRESH.
"because if they were in talks to sell a firesale give away,then they would`nt be hiring"
WRONG!! Just look at the most recent deal with KITE. I checked their website the next day after the deal was announced and they had jobs listed for positions they were looking to fill. Just because you're in negotiations doesn't mean you stop trying to move the company forward
If investors are covering their short positions. Why does the pps just continue to drop? Trying to make a decision what to do with my long shares after the short interest is reported later. Why does it feel like the Tutes are dumping all their shares and by time we find out in November it will be to late.
Does short interest get reported tomorrow? This could be a big tale of what's going on.
Why has Adage not filed a 13g yet for the change in ownership percentage from the last sale of 600k
You don't see any bad news,lol!! DELAYS can sometimes be the worse news
"Maybe Dan asked Adage to hurt the stock?" Wtf? Listen to yourselves people!
longx, thanks for the post and the info in it.
Let's see if Adage files after hours today
Wow, Lambardo has nailed it. When it comes to creating shareholder value.
Adage's last 600,000 sold might have put them just under 10%. Wonder what's taking them so long to file the 13a/g this time. After the last sale they filed it right away. Guess will find out by next week along with the new short interest numbers
Thanks Dew, interesting because that will show the percentage of change in ownership. Or maybe they plan on dumping more shares within those 10 days. We shall see!!
Aduro moving things along nicely. Advaxis nothing but delays and trials that never start, amateur hour over here. PLEASE JUST SELL THE COMPANY ALREADY
Does anybody know why Adage has not or if they have to file a 13g/a after the most recent sale?
So I was incorrect. Here it is...
"Under the agreement, Aratana made a one-time upfront payment to Advaxis of $1 million and an additional $1.5 million equity investment in Advaxis common stock and warrants. Aratana agreed to pay up to an additional $6 million in clinical and regulatory milestones for each of the four products, assuming approvals in both cats and dogs in both United States and the European Union. In addition, Aratana agreed to pay up to $28.5 million in commercial milestones. Upon regulatory approval and commercialization of the immunotherapies, Aratana agreed to pay Advaxis a tiered royalty ranging from mid-single digit to 10% on net sales."